Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant

University of Toronto

$936,791.00

Functional Analysis of a Eukaryotic Kinome

EF 2010-11

Résumé
Cancer is a genetic disease caused by inappropriate, unrestrained cell growth and division. The regulators of cell division are remarkably conserved, with the same players functioning to promote or inhibit these processes in simple one-celled organisms to human cells. Dr. Andrews' group will make use of the powerful genetics and experimental accessibility of a simple model organism system - the budding yeast - to systematically explore a family of key cell cycle regulators called kinases. Advances in genome-scale technologies, genome sequencing projects and astounding technological developments mean that model organism systems remain ensconced at the frontiers of biomedical research and will continue to produce fundamental new insights into cell division and cancer in the coming decade. The overall goal of Dr. Andrews' research program is to set the stage for the development of new cancer therapies that manipulate the cell division cycle, through the development of a comprehensive 'road-map' describing cell division and cell polarity pathways in normal cells - this roadmap will provide the essential foundation for producing a view of how this map is redrawn in cancer cells.
Programme
Operating Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
227802
Name
Andrews Brenda J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Genomics: Systems and computational biology
Projecttitle
Functional Analysis of a Eukaryotic Kinome
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$936,791
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Cancer; Functional Genomics; Genetic Networks; Molecular Biology; Protein Kinase; Yeast Genetics
Abstract
Cancer is a genetic disease caused by inappropriate, unrestrained cell growth and division. The regulators of cell division are remarkably conserved, with the same players functioning to promote or inhibit these processes in simple one-celled organisms to human cells. Dr. Andrews' group will make use of the powerful genetics and experimental accessibility of a simple model organism system - the budding yeast - to systematically explore a family of key cell cycle regulators called kinases. Advances in genome-scale technologies, genome sequencing projects and astounding technological developments mean that model organism systems remain ensconced at the frontiers of biomedical research and will continue to produce fundamental new insights into cell division and cancer in the coming decade. The overall goal of Dr. Andrews' research program is to set the stage for the development of new cancer therapies that manipulate the cell division cycle, through the development of a comprehensive 'road-map' describing cell division and cell polarity pathways in normal cells - this roadmap will provide the essential foundation for producing a view of how this map is redrawn in cancer cells.
Competitiondate
201103
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Andrews, Brenda J
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $936,791~ $0~